Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS)

November 2012

You'll hear about Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS).

It's not a completely new drug.

It's the active metabolite of leflunomide (Arava, etc)...the immunomodulator used to slow progression of rheumatoid arthritis.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber's Letter includes:

12 issues every year, with brief articles about new meds and guidelines
48+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

Table of Contents

Diabetes whether EVERY patient with type 2 diabetes should get an ACE inhibitor or ARB, aspirin, and statin
Asthma inhaled corticosteroids PRN for some asthma patients
Asthma controversy about whether long-acting beta-agonists (salmeterol, etc) should be stopped once asthma is controlled
Cardiology bigger push to limit NSAIDs after an MI INDEFINITELY
Cardiology myths about aspirin
Infectious Diseases Many patients with strep throat get an antibiotic dosed more frequently than necessary
Diabetes Treating diabetes in the elderly brings up challenges
Diabetes Does it ever make sense to dose extended-release metformin or basal insulin twice daily
Obesity & Weight Loss Patients will ask for Qsymia
Hepatitis C hepatitis C testing for ALL baby boomers
Gastroenterology new bowel prep called Prepopik (PREP-oh-pik)
Thyroid Disorders the best way to take levothyroxine
Multiple Sclerosis Aubagio (oh-BAH-gee-oh, teriflunomide), the second ORAL option for relapsing forms of multiple sclerosis (MS)